Artiva Biotherapeutics, Inc. Common Stock

ARTVNASDAQ • USD
6.89 USD
↘ 0.38 (5.17%)🟢LIVE (AS OF 09:33 AM EDT)
🟢Market: OPEN

ARTV is currently priced at $6.89. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ARTV is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 6, 2026.

Open?$7.27
High?$7.27
Low?$6.88
Prev. Close?$7.27
Volume?23.7K
Avg. Volume?449.7K
VWAP?$7.11
Rel. Volume?0.05x
Bid / Ask
Bid?$6.31 × 100
Ask?$8.37 × 100
Spread?$2.06
Midpoint?$7.34
Valuation & Ratios
Market Cap?355.4M
Shares Out?48.9M
Float?13.6M
Float %?27.9%
P/E Ratio?N/A
P/B Ratio?1.02
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Employees
115
Market Cap
355.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
20
Piotroski F-Score?0/9Weak
Altman Z-Score?8.89Safe
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.15%High
Short Interest?2.1M
Days to Cover?6.7
Free Float13.6M
Avg Daily Volume310.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?24.16Strong
Quick Ratio?24.16Strong
Cash Ratio?20.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
1.02CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-26.1%WEAK▾
ROA?
S&P
3
-24.6%WEAK▾
Cash Flow & Enterprise
FCF?$-76910000
Enterprise Value?$54.0M
Fundamentals ratios updated end of day